Browsing Tag
SanegeneBio
1 post
Why Innovent Biologics and SanegeneBio believe IBI3016 could change hypertension treatment
Innovent Biologics and SanegeneBio reveal strong Phase 1 data for IBI3016 at AHA 2025. Discover how this RNAi therapy could redefine hypertension treatment.